Miehlke S et al. |
Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin. |
2006 |
Aliment. Pharmacol. Ther. |
pmid:16842467
|
Gu Q et al. |
Effect of cyclo-oxygenase inhibitors on Helicobacter pylori susceptibility to metronidazole and clarithromycin. |
2004 |
Aliment. Pharmacol. Ther. |
pmid:15352916
|
Ahuja V et al. |
Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9678815
|
Grübel P and Cave DR |
Factors affecting solubility and penetration of clarithromycin through gastric mucus. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9678818
|
Neville PM et al. |
The optimal antibiotic combination in a 5-day Helicobacter pylori eradication regimen. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10215734
|
Hoffman JS et al. |
Efficacy of a 1-week regimen of ranitidine bismuth citrate in combination with metronidazole and clarithromycin for Helicobacter pylori eradication. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10215735
|
You JH et al. |
Economic analysis of four triple regimens for the treatment of Helicobacter pylori-related peptic ulcer disease in in-patient and out-patient settings in Hong Kong. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11421876
|
De Francesco V et al. |
Effectiveness and pharmaceutical cost of sequential treatment for Helicobacter pylori in patients with non-ulcer dyspepsia. |
2004 |
Aliment. Pharmacol. Ther. |
pmid:15113366
|
Pellegrini M et al. |
Is a long-term ranitidine-based triple therapy against Helicobacter pylori only a heritage of the past? A prospective, randomized clinicopharmacological study. |
2005 |
Aliment. Pharmacol. Ther. |
pmid:16098001
|
Gisbert JP et al. |
Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week-a meta-analysis of efficacy. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10971230
|
Bigard MA et al. |
One-week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia: influence of dosage of omeprazole and clarithromycin. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9690730
|
Wong BC et al. |
Triple therapy for Helicobacter pylori eradication is more effective than long-term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer: a prospective long-term follow-up study. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10102962
|
Xiao SD et al. |
High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and clarithromycin triple therapy for 1 week. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10102963
|
Liu WZ et al. |
Furazolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10102964
|
Huang J and Hunt RH |
Clarithromycin-based triple therapies. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10102978
|
Wurzer H et al. |
Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study Group. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9354205
|
Harris A |
H. pylori eradication by LAC. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9354216
|
Osato MS et al. |
Comparative efficacy of new investigational agents against Helicobacter pylori. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11284777
|
Weldon MJ et al. |
A seven-day Helicobacter pylori treatment regimen using clarithromycin, omeprazole and tripotassium dicitrato bismuthate. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8791951
|
Tursi A et al. |
Low-dose omeprazole plus clarithromycin and either tinidazole or amoxycillin for Helicobacter pylori infection. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8791952
|